P3 Health Partners Inc. has entered into a new financing agreement through its subsidiary, P3 Health Group, LLC, involving an unsecured promissory note and warrants to purchase shares of Class A Common Stock with VBC Growth SPV 5, LLC, a Delaware-based entity managed by Chicago Pacific Founders GP III, L.P. This agreement, effective May 29, 2025, was approved by a committee of independent directors. Concurrently, P3 LLC amended its existing Term Loan Agreement with CRG Servicing LLC, allowing for the issuance of the promissory note and entering into a subordination agreement with VBC 5. Under this agreement, VBC 5 has agreed to subordinate its payment rights to the existing lenders, requiring P3 LLC to pay interest in-kind. These strategic financial arrangements aim to bolster P3 Health Partners' financial flexibility and growth potential.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。